[Plasmapheresis for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Odaka
Masaaki
M
Department of Neurology, Dokkyo University School of Medicine.
D001323:Autoantibodies / Q000302:isolation & purification; D019317:Evidence-Based Medicine; D005732:Gangliosides / Q000276:immunology; D020275:Guillain-Barre Syndrome / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000302:isolation & purification; D007075:Immunoglobulin M / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D018992:Myelin-Associated Glycoprotein / Q000276:immunology; D010951:Plasma Exchange / Q000009:adverse effects / Q000379:methods*
D001323:Autoantibodies; D005732:Gangliosides; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; D018992:Myelin-Associated Glycoprotein